top of page

DF6215

A Novel Alpha-Active IL-2-Fc Has Expanded Therapeutic Index And Robust Monotherapy Efficacy In Mouse Cancer Models And Strong Synergy With PD-1 Blockade

20241023 SITC 2024 DF6215 poster_no QR.jpg
DragonflyTherapeutics_Logo_Color_Final_07.09.16.png
Activating the Immune System to Fight Disease
Contact

DRAGONFLY Therapeutics, Inc.
180 3rd Avenue, Sixth Floor

Waltham, MA 02451
United States

1-617-588-0086

​

Sitemap
  • Twitter
  • LinkedIn

©2024 Dragonfly Therapeutics - All Rights Reserved

bottom of page